Hepatectomy for hepatocellular carcinoma larger than 10 cm: preoperative risk stratification to prevent futile surgery.

C Lim, P Compagnon, M Sebagh, C Salloum, Julien CALDERARO, Alain LUCIANI, G Pascal, A Laurent, E Levesque, U Maggi, Cyrille FERAY, D Cherqui, D Castaing, D Azoulay,

HPB (Oxford) 01/07/2015;17(7) : 611-623 10.1111/hpb.12416 16/05/2015

Low cross-neutralization of hepatitis C correlates with liver disease in immunocompromized patients.

G Maurin, B Halgand, Patrice BRUSCELLA, J Fresquet, JC Duclos-Vallee, AM Roque-Afonso, FL Cosset, D Samuel, D Lavillette, Cyrille FERAY,

AIDS. 01/06/2015;29(9) : 1025-33 10.1097/QAD.0000000000000651.

Patient with decompensated hepatitis C virus-related cirrhosis delisted for liver transplantation after successful

Isaac RUIZ, Cyrille FERAY, Jean-Michel PAWLOTSKY, Christophe HEZODE,

Liver Transpl. 01/03/2015;21(3) : 408-409 10.1002/lt.2405 20/01/2015

Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study.

JM Michot, D Canioni, H Driss, L Alric, P Cacoub, F Suarez, D Sibon, C Thieblemont, J Dupuis, B Terrier, Cyrille FERAY, H Tilly, S Pol, V Leblond, C Settegrana, P Rabiega, Y Barthe, H Hendel-Chavez, F Nguyen-Khac, H Merle-Beral, F Berger, T Molina, F Charlotte, F Carrat, F Davi, O Hermine, C Besson,

Am J Hematol. 01/03/2015;90(3) : 197-203 10.1002/ajh.23889. 24/11/2014

Long-term results of combined liver-kidney transplantation for primary hyperoxaluria type 1: the French experience.

P Compagnon, P Metzler, D Samuel, C Camus, P Niaudet, A Durrbach, P Lang, D Azoulay, C Duvoux, F Bayle, J Rivalan, P Merville, G Pascal, E Thervet, A Bensman, L Rostaing, G Deschenes, J Morcet, Cyrille FERAY, K Boudjema,

Liver Tanspl. 01/12/2014;20(12) : 1475-1485 10.1002/lt.24009.

A novel method to identify routes of hepatitis C virus transmission.

Cyrille FERAY, J Bouscaillou, B Falissard, MK Mohamed, N Arafa, I Bakr, M El-Hoseiny, ME Daly, S El-Kafrawy, S Plancoulaine, M Abdel-Hamid, V Thiers, A Fontanet,

PLoS One. 23/01/2014;9(1) : e86098 10.1371/journal.pone.0086098.

Should we screen blood products for hepatitis E virus RNA ?

Cyrille FERAY, Jean-Michel PAWLOTSKY, AM Roque-Afonso, D Samuel, D Dhumeaux,

Lancet. 18/01/2014;383(9913) : 218 10.1016/S0140-6736(14)60072-6.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

Christophe HEZODE, H Fontaine, C Dorival, D Larrey, F Zoulim, V Canva, V De Ledinghen, T Poynard, D Samuel, M Bourliere, JP Zarski, JJ Raabe, L Alric, P Marcellin, G Riachi, PH Bernard, V Loustaud-Ratti, S Metivier, A Tran, L Serfaty, A Abergel, X Causse, V Di Martino, D Guyader, D Lucidarme, V Grando-Lemaire, P Hillon, Cyrille FERAY, T Dao, P Cacoub, I Rosa, P Attali, V Petrov-Sanchez, Y Barthe, Jean-Michel PAWLOTSKY, S Pol, F Carrat, JP Bronowicki,

J Hepatol 01/09/2013;59(3) : 434-441 10.1016/j.jhep.2013.04.035 10/05/2013